Literature DB >> 18365234

Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system.

Glynis L Kolling1, Fumiko Obata, Lisa K Gross, Tom G Obrig.   

Abstract

Shiga toxin-producing Escherichia coli causes hemolytic uremic syndrome, a constellation of disorders that includes kidney failure and central nervous system dysfunction. Shiga toxin binds the amphipathic, membrane-bound glycolipid globotriaosylceramide (Gb(3)) and uses it to enter host cells and ultimately cause cell death. Thus, cell types that express Gb(3) in target tissues should be recognized. The objective of this study was to determine whether immunohistologic detection of Gb(3) was affected by the method of tissue preparation. Tissue preparation included variations in fixation (immersion or perfusion) and processing (paraffin or frozen) steps; paraffin processing employed different dehydration solvents (acetone or ethanol). Perfusion-fixation in combination with frozen sections or acetone-dehydrated tissue for paraffin sections resulted in specific recognition of Gb(3) using immunohistochemical or immunofluorescent methods. In the mouse tissues studied, Gb(3) was associated with tubules in the kidney and neurons in the nervous system. On the other hand, Gb(3) localization to endothelial cells was determined to be an artifact generated due to immersion-fixation or tissue dehydration with ethanol. This finding was corroborated by glycolipid profiles from tissue subjected to dehydration; namely Gb(3) was subject to extraction by ethanol more than acetone during tissue dehydration. The results of this study show that tissue preparation is crucial to the persistence and preservation of the glycolipid Gb(3) in mouse tissue. These methods may serve as a basis for determining the localization of other amphipathic glycolipids in tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365234     DOI: 10.1007/s00418-008-0417-8

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  19 in total

1.  Localization of verotoxin receptors in nervous system.

Authors:  J Ren; I Utsunomiya; K Taguchi; T Ariga; T Tai; Y Ihara; T Miyatake
Journal:  Brain Res       Date:  1999-04-17       Impact factor: 3.252

2.  IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES.

Authors:  H G ROSE; M OKLANDER
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

3.  Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model.

Authors:  Michael Mattocks; Maria Bagovich; Maria De Rosa; Steve Bond; Beth Binnington; Vanessa I Rasaiah; Jeffrey Medin; Clifford Lingwood
Journal:  FEBS J       Date:  2006-05       Impact factor: 5.542

4.  Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation.

Authors:  A Abe; S Gregory; L Lee; P D Killen; R O Brady; A Kulkarni; J A Shayman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.

Authors:  Niels W P Rutjes; Beth A Binnington; Charles R Smith; Mark D Maloney; Clifford A Lingwood
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

6.  Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.

Authors:  Zuhal Ergonul; Frederic Clayton; Agnes B Fogo; Donald E Kohan
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

7.  Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products.

Authors:  Yuko Fujii; Shin-ichiro Numata; Yoko Nakamura; Takashi Honda; Keiko Furukawa; Takeshi Urano; Joelle Wiels; Makoto Uchikawa; Noriyuki Ozaki; Sei-ichi Matsuo; Yasuo Sugiura; Koichi Furukawa
Journal:  Glycobiology       Date:  2005-08-03       Impact factor: 4.313

8.  Verotoxin-binding in human renal sections.

Authors:  C A Lingwood
Journal:  Nephron       Date:  1994       Impact factor: 2.847

9.  Studies in lipid histochemistry. X. Lipids in paraffin sections.

Authors:  M Elleder; Z Lojda
Journal:  Histochemie       Date:  1973-02-06

10.  Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.

Authors:  Fumiko Obata; Koujiro Tohyama; Adrian D Bonev; Glynis L Kolling; Tiffany R Keepers; Lisa K Gross; Mark T Nelson; Shigehiro Sato; Tom G Obrig
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

View more
  16 in total

Review 1.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

Review 2.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

Review 3.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins.

Authors:  Radhia Mahfoud; Adam Manis; Beth Binnington; Cameron Ackerley; Clifford A Lingwood
Journal:  J Biol Chem       Date:  2010-08-17       Impact factor: 5.157

5.  Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.

Authors:  Kristin A D Sauter; Angela R Melton-Celsa; Kay Larkin; Megan L Troxell; Alison D O'Brien; Bruce E Magun
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

6.  Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol.

Authors:  D Otali; Q He; C R Stockard; W E Grizzle
Journal:  Biotech Histochem       Date:  2013-01-23       Impact factor: 1.718

7.  Shiga toxin 2 targets the murine renal collecting duct epithelium.

Authors:  Mitchell A Psotka; Fumiko Obata; Glynis L Kolling; Lisa K Gross; Moin A Saleem; Simon C Satchell; Peter W Mathieson; Tom G Obrig
Journal:  Infect Immun       Date:  2009-01-05       Impact factor: 3.441

8.  Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib.

Authors:  Samuel M Stone; Cheleste M Thorpe; Amrita Ahluwalia; Arlin B Rogers; Fumiko Obata; Aimee Vozenilek; Glynis L Kolling; Anne V Kane; Bruce E Magun; Dakshina M Jandhyala
Journal:  Front Cell Infect Microbiol       Date:  2012-11-08       Impact factor: 5.293

9.  Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Toxins (Basel)       Date:  2010-08       Impact factor: 4.546

10.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.

Authors:  Tom G Obrig
Journal:  Toxins (Basel)       Date:  2010-12-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.